Trial intelligence / Profile preview

Sugammadex for IONM During Thyroid Surgery

NCT03911232Completed

Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Start
Mar 2015
Primary completion
Mar 2016
Countries
1
01

Overview

Randomised, open-label trial of Sugammadex in laryngeal nerve injury (RLNI), sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Primary endpoint: Restoration of neuromuscular function suppressed by rocuronium at 1 month. Started Mar 2015; status: completed.

02

Drugs

Sugammadex
03

Conditions

laryngeal nerve injury (RLNI)

Beyond the preview

Go deeper on NCT03911232.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03911232.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call